apomorphine has been researched along with cholecystokinin in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (62.86) | 18.7374 |
1990's | 11 (31.43) | 18.2507 |
2000's | 2 (5.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beinfeld, MC; Brog, JS | 1 |
Fukamauchi, F; Shibuya, H; Yoshikawa, T | 1 |
Abe, E; Itoh, T; Itsukaichi, O; Masuda, Y; Murai, S; Ohkubo, N; Shoji, S | 1 |
Benoliel, JJ; Catelon, J; De Vitry, F; Hamon, M; Hillion, J; Thibault, J | 1 |
Czachura, JF; Howbert, JJ; Rasmussen, K; Stockton, ME | 1 |
Harro, J; Lang, A; Pôld, A; Soosaar, A; Vasar, E | 1 |
Baldwin, BA; Ebenezer, IS; Forsling, ML; Parrott, RF | 1 |
Itoh, S; Takashima, A | 1 |
Zetler, G | 1 |
Agnati, LF; Battistini, N; Benfenati, F; Calza, L; Fuxe, K; Giardino, L; Guidolin, D; Ruggeri, M; Vanderhaeghen, JJ; Zoli, M | 1 |
Bunney, BS; Chiodo, LA; Freeman, AS | 2 |
Blaha, CD; Fibiger, HC; Lane, RF; Phillips, AG | 1 |
Blaha, CD; Lane, RF; Phillips, AG | 1 |
Pfaus, JG; Phillips, AG | 1 |
De Witte, P; Gewiss, M; Goldman, S; Roques, B; Swanet, E; Vanderhaeghen, JJ | 1 |
Freedman, R; Henschen, A; Hoffer, B; Olson, L; Seiger, A; Vanderhaeghen, JJ | 1 |
Blumstein, LK; Crawley, JN; Paul, SM; Stivers, JA | 1 |
Furuta, Y; Hashimoto, K; Ishii, Y; Iwatsuki, K | 1 |
Antin, J; Gibbs, J; Holt, J; Smith, GP; Young, RC | 1 |
Chase, TN; Cohen, SL; Knight, M; Tamminga, CA | 1 |
Kovács, GL; Penke, B; Szabó, G; Telegdy, G | 1 |
Ellinwood, EH; Rockwell, WJ; Wagoner, N | 1 |
Etienne, P; Eugenio, H; Guyda, H; Lal, S; Lizondo, E; Nair, NP; Thavundayil, J; Wood, PL | 1 |
Etienne, P; Guyda, H; Lal, S; Nair, NP; Thavundayil, JX; Wood, PL | 1 |
Hommer, DW; Skirboll, LR | 1 |
Krauss, J; Meyer, DK | 1 |
Eugenio, H; Guyda, H; Lal, S; Lizondo, E; Nair, NP | 1 |
Forsling, ML; Parrott, RF | 1 |
Christoffersen, CL; Meltzer, LT; Razmpour, A; Serpa, KA | 1 |
Felicio, LF; Nasello, AG; Palermo-Neto, J; Silva, AM; Tieppo, CA | 1 |
Feifel, D; Swerdlow, NR | 1 |
Feifel, D; Priebe, K; Shilling, PD | 1 |
Felicio, LF; Nasello, AG; Tieppo, CA | 1 |
1 review(s) available for apomorphine and cholecystokinin
Article | Year |
---|---|
Interactions between mesolimbic dopamine neurons, cholecystokinin, and neurotensin: evidence using in vivo voltammetry.
Topics: Animals; Apomorphine; Cholecystokinin; Dopamine; Electrodes; Limbic System; Mesencephalon; Neurons; Neurotensin; Nucleus Accumbens; Sincalide | 1988 |
34 other study(ies) available for apomorphine and cholecystokinin
Article | Year |
---|---|
Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Apomorphine; Caudate Nucleus; Cerebral Cortex; Cholecystokinin; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Hippocampus; Male; Methyltyrosines; Putamen; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1992 |
Pre-synaptic dopaminergic control mechanisms for CCK-8 like immunoreactivity in the rat medial frontal cortex.
Topics: Animals; Apomorphine; Behavior, Animal; Cholecystokinin; Dopamine; Dopamine Agents; In Vitro Techniques; Male; Microinjections; N-Methylaspartate; Nerve Degeneration; Neurons; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine | 1992 |
Pharmacological properties of ceruletide in the vertical and horizontal locomotor activities of mice.
Topics: Animals; Apomorphine; Ceruletide; Cholecystokinin; Clonidine; Dopamine; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred Strains; Motor Activity; Sympathetic Nervous System | 1992 |
Dopamine increases the expression of tyrosine hydroxylase and aromatic amino acid decarboxylase in primary cultures of fetal neurons.
Topics: Animals; Apomorphine; Aromatic-L-Amino-Acid Decarboxylases; Brain Stem; Cells, Cultured; Cholecystokinin; Dopamine; Female; Haloperidol; Hypothalamus; Immunohistochemistry; Neurons; Phenotype; Rats; Rats, Inbred Strains; Tyrosine 3-Monooxygenase | 1991 |
Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Cholecystokinin; Dopamine; Male; Mesencephalon; Neurons; Pyrazoles; Rats; Rats, Inbred Strains; Schizophrenia | 1991 |
Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
Topics: Amphetamine; Animals; Apomorphine; Benzodiazepinones; Ceruletide; Cholecystokinin; Devazepide; Male; Mice; Motor Activity; Phenylurea Compounds; Receptors, Cholecystokinin | 1991 |
Hormonal effects of apomorphine and cholecystokinin in pigs: modification of the response to cholecystokinin by a dopamine antagonist (metoclopramide) and a kappa opioid agonist (PD117302).
Topics: Animals; Apomorphine; Cholecystokinin; Dopamine Antagonists; Feeding Behavior; Female; Hydrocortisone; Lypressin; Male; Metoclopramide; Pyrroles; Swine; Thiophenes | 1991 |
Neuropharmacological properties of V-9-M, a putative neuropeptide derived from procholecystokinin, in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Body Temperature; Cholecystokinin; Eating; Injections, Intraventricular; Male; Methamphetamine; Motor Activity; Nervous System; Pentobarbital; Peptide Fragments; Protein Precursors; Rats; Rats, Inbred Strains; Sleep; Thyrotropin-Releasing Hormone | 1989 |
Clonidine sensitizes mice for apomorphine-induced stereotypic gnawing: antagonism by neuroleptics and cholecystokinin-like peptides.
Topics: Animals; Antipsychotic Agents; Apomorphine; Cholecystokinin; Clonidine; Haloperidol; Humans; Male; Mice; Oligopeptides; Stereotyped Behavior; Thioxanthenes; Trifluoperazine | 1985 |
Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat. Studies on their functional meaning.
Topics: Aging; Animals; Apomorphine; Brain; Cholecystokinin; Haloperidol; Male; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide; Tyrosine 3-Monooxygenase | 1985 |
Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.
Topics: Animals; Anorexia Nervosa; Antipsychotic Agents; Apomorphine; Brain; Cholecystokinin; Glutamine; Humans; Mesencephalon; Neurons; Proglumide; Receptors, Dopamine; Schizophrenia | 1985 |
Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide.
Topics: Action Potentials; Animals; Apomorphine; Brain; Cerebral Cortex; Cholecystokinin; Dopamine; Enkephalin, Methionine; gamma-Aminobutyric Acid; Glutamine; Male; Neurotensin; Proglumide; Rats; Receptors, Neurotransmitter; Sodium Glutamate; Substantia Nigra | 1987 |
Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat.
Topics: Animals; Apomorphine; Cell Membrane; Cholecystokinin; Dopamine; Electrochemistry; Male; Nucleus Accumbens; Proglumide; Rats; Rats, Inbred Strains; Septal Nuclei | 1987 |
Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine.
Topics: Animals; Apomorphine; Cholecystokinin; Copulation; Dose-Response Relationship, Drug; Ejaculation; Glutamine; Male; Proglumide; Rats; Sexual Behavior, Animal | 1987 |
Psychopharmacological profile of cholecystokinin using the self-stimulation and the drug discrimination paradigms.
Topics: Amphetamine; Animals; Apomorphine; Chlorpromazine; Cholecystokinin; Discrimination Learning; Dose-Response Relationship, Drug; Haloperidol; Male; Rats; Rats, Inbred Strains; Self Stimulation | 1985 |
Combined grafts of the ventral tegmental area and nucleus accumbens in oculo. Histochemical and electrophysiological characterization.
Topics: Animals; Apomorphine; Cell Division; Cell Survival; Cholecystokinin; Electric Conductivity; Eye; Female; Fetus; Microscopy, Fluorescence; Nucleus Accumbens; Ocular Physiological Phenomena; Rats; Rats, Inbred Strains; Septal Nuclei; Tegmentum Mesencephali | 1985 |
Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
Topics: Animals; Apomorphine; Behavior, Animal; Catheters, Indwelling; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immune Sera; Injections, Intraventricular; Male; Motor Activity; Nucleus Accumbens; Rats; Stereotyped Behavior | 1985 |
Modification by drugs of the secretagogue effect of dopamine on the pancrease.
Topics: Animals; Apomorphine; Catecholamines; Cholecystokinin; Dihydroxyphenylalanine; Dogs; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Female; Hydroxydopamines; Male; Methyldopa; Norepinephrine; Octopamine; Pancreas; Perfusion; Reserpine; Secretin; Spectrometry, Fluorescence; Stimulation, Chemical; Time Factors | 1974 |
Cholecystokinin does not produce bait shyness in rats.
Topics: Animals; Apomorphine; Avoidance Learning; Cholecystokinin; Eating; Inhibition, Psychological; Male; Rats; Saccharin; Satiation; Taste; Water Deprivation | 1974 |
Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Cholecystokinin; Extinction, Psychological; Female; Haloperidol; Humans; Hypnotics and Sedatives; Peptide Fragments; Rats; Rats, Inbred Strains; Sincalide; Stereotyped Behavior; Tetragastrin | 1982 |
Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Cholecystokinin; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Humans; Male; Methyltyrosines; Mice; Naloxone; Receptors, Dopamine; Sincalide; Stereotyped Behavior | 1981 |
Cholecystokinin (CCK): ascension from gut to brain.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Bucladesine; Ceruletide; Cholecystokinin; Chronic Disease; Dopamine; Humans; Rats; Rats, Inbred Strains; Schizophrenia; Species Specificity | 1983 |
A caerulein-sensitive potentiation of the behavioral effects of apomorphine by dibutyryl-cAMP.
Topics: Animals; Apomorphine; Bucladesine; Ceruletide; Cholecystokinin; Dibutyryl Cyclic GMP; Injections, Intraventricular; Male; Rats; Rats, Inbred Strains | 1983 |
Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
Topics: Adolescent; Adult; Apomorphine; Brain; Ceruletide; Cholecystokinin; Growth Hormone; Homovanillic Acid; Humans; Male; Prolactin; Receptors, Dopamine; Sincalide; Synaptic Transmission | 1983 |
CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man.
Topics: Adult; Apomorphine; Cholecystokinin; Drug Interactions; Growth Hormone; Humans; Male; Prolactin; Receptors, Dopamine; Time Factors | 1984 |
Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons.
Topics: Animals; Apomorphine; Ceruletide; Cholecystokinin; Dopamine; Male; Neurons; Rats; Rats, Inbred Strains | 1983 |
Dopamine modulates cholecystokinin release in neostriatum.
Topics: Animals; Apomorphine; Calcium; Caudate Nucleus; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Kainic Acid; Putamen; Rats; Receptors, Dopamine; Tetrodotoxin; Veratridine | 1983 |
Effect of CCK-33 on prolactin and apomorphine-induced growth hormone secretion in man.
Topics: Adult; Apomorphine; Cholecystokinin; Growth Hormone; Humans; Male; Prolactin | 1983 |
The CCKA receptor antagonist devazepide inhibits the effect of apomorphine on vasopressin release in pigs.
Topics: Animals; Apomorphine; Benzodiazepinones; Cholecystokinin; Devazepide; Drug Interactions; Lypressin; Nausea; Receptors, Cholecystokinin; Swine; Vomiting | 1994 |
Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
Topics: Animals; Apomorphine; Benzodiazepinones; Cholecystokinin; Devazepide; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Indoles; Male; Meglumine; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substantia Nigra; Tegmentum Mesencephali | 1993 |
Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
Topics: Analysis of Variance; Animals; Apomorphine; Cholecystokinin; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Injections, Intraventricular; Male; Rats; Rats, Wistar; Sincalide; Stereotyped Behavior | 1995 |
The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin.
Topics: Acoustic Stimulation; Animals; Apomorphine; Cholecystokinin; Dopamine Agonists; Injections; Limbic System; Male; Nucleus Accumbens; Rats; Rats, Wistar; Reflex, Startle | 1997 |
Startle and sensorimotor gating in rats lacking CCK-A receptors.
Topics: Acoustic Stimulation; Amphetamine; Animals; Apomorphine; Brain; Cholecystokinin; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Haloperidol; Male; Motor Activity; Neural Inhibition; Rats; Rats, Inbred OLETF; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Reflex, Startle | 2001 |
Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.
Topics: Amphetamines; Animals; Apomorphine; Cholecystokinin; Dopamine; Dopamine Agonists; Drug Interactions; Male; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Synapses; Tetragastrin; Time Factors | 2001 |